Generic Name and Formulations:
Diphenhydramine HCl 25mg; liquicaps.
Procter & Gamble Pharmaceuticals
Indications for ZZZQUIL:
Relief of occasional sleeplessness.
50mg at bedtime as needed.
Asthma. Emphysema. Chronic bronchitis. Glaucoma. Cardiovascular disease. GI or GU obstruction. Reevaluate if no response or symptoms persist after 2 weeks. Pregnancy. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant other diphenhydramine products (including topicals): not recommended. Additive effects with other antihistamines, anticholinergics, sedatives, tranquilizers or other nighttime cold/fu products (eg, NyQuil); avoid.
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
Liquicaps—12, 24, 48; Liq—6oz, 12oz
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|